comparision of efficacy of intradermal tranxamic acid injection with fractional Q-Switch Nd-yag laser for melasma treatment
Phase 3
Recruiting
- Conditions
- Chloasmamelasma.
- Registration Number
- IRCT20180418039349N1
- Lead Sponsor
- Skin and Stem Cell Research Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 28
Inclusion Criteria
women over the age of 18
moderate to severe melasma
Exclusion Criteria
pregnancy
lactation
patients who have received contraceptive drugs in the last 12 months
Patients with hemorrhagic or anticoagulant abnormalities
anticoagulant dug using
receiving another treatment for melasma at the same time
receive topical treatment for melasma for example hydroquinone one month before treatment.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method